![]() |
Dr. Aroop Dutta, Excel Matrix Biologics, Hyderabad Dr. Dutta, is the Managing Director of ExCel Matrix Biological Devices P. Ltd., a tissue engineering start-up developing multiple commercial technologies in the area of three dimensional cell culture tools and regenerative medicine.
|
3D Cell Culture Tools for Regenerative Medicine Research and Development | |
![]() |
Dr. B. M. Gandhi, CEO, Neo Biomed. Former Advisor, Govt. of India, Dept. of Biotechnology With a wealth of experience spanning more than 35 years and several senior goverment positions, Dr. Gandhi brings his unique perspective on the state of stem cell research and therapy in India.
|
Regenerative Medicine Global Regulatory Environment | |
![]() |
Dr. Deepa Bhartiya, Senior Scientist, National Institute for Research in Reproductive Health, India
A Ph.D in Zoology from Central Drug Research Institute, Lucknow and a Post Doc. Fellow from Dept. of Pathology, Bethesda , Maryland , USA. Dr. Bhartiya's research interest is in pluripotent stem cells. She has two in-house derived human embryonic stem cell lines derived on human feeder support.
|
Pluripotent Stem Cells in Adult Body Tissues | |
![]() |
Dr. Geeta Vemuganti, Dean, School of Medical Sciences, University of Hyderabad Dr. Vemuganti has an MBBS, DCP from Osmania University, and MD (Pathology) from Nizam’s Institute of Medical Sciences, New Delhi. A physician-pathologist by training, Dr. Vemuganti is on the forefront of research in ocular pathology and stem cell research. Her areas of interest include in corneal infections, genotype-phenotype correlation in corneal dystrophies, oculo-adenexal tumors; especially retinoblastoma, ocular surface squamous cell carcinoma.
|
||
![]() |
Dr. Gopal Pande, Scientific Officer, Center for Cellular and Molecular Biology, Hyderabad Dr. Pande has more than 25 years experience in the field of cell biology. He is presently studying the expansion of bone marrow stem cells and their differentiation into hepatocytes.
|
||
![]() |
Dr. GPV Subbaiah, Chief Spine Surgeon, Global Hospitals, India An MS (Orthopedic) from Guntur Medical College, Dr. Subbaiah has conducted around 1500 spine surgeries in various disciplines like fixations, deformity corrections, MAST & dynamic stabilization-the most recent trend in spine surgeries.
|
Cell based therapies for spinal cord injury | |
![]() |
Dr. Gururaj Rao, Research Director, International Stemcell Services Limited Dr. Rao has a Ph. D in Pharmacy/ Gene Delivery from University of North Carolina at Chapel Hill, USA and has done his post-doctoral work in pharmaceutical science and neuroscience at the University of Florida, Gainesville. Dr. Rao's interest lies in translational research aiming to improve the clinical feasibility of stem cell and gene therapy technologies.
|
Clinical studies using adult stem cells: an overview | |
![]() |
Dr. H. N. Madhavan, President, Vision Research Foundation, Director and Professor of Microbiology, Sankara Nethralaya Dr. H.N. Madhavan is a Founder Member of Indian Association of Medical Microbiologists and is the President of Vision Research Foundation, Sankara Nethralaya. He has been an undergraduate and a postgraduate teacher in medical microbiology for more than 50 years in medical institutions in India and abroad.
|
Annual Oration | |
![]() |
Dr. John Wotherspoon, Business Director, Cell Analysis, BD Biosciences, Asia Pacific A management executive with Becton Dickinson, Dr. Wotherspoon has more than 20 years experience in functional cell biology assessed through flow cytometry and monoclonal antibody technology.
|
An Update on Cell Sorting Technologies for Cell Therapy Enablement | |
Dr. Jyothsna Rao, Research Director, Sri Raghavendra Biotechnologies Pvt. Ltd.; Secretary, SRMTE With an M.S in Immunology from UAMS, Arkansas, USA and a Ph. D in Cell Biology from NCBS, Bangalore, Dr. Jyothsna has more than 15 years experience in immunology and stem cell-related research. Her special interests lie in development of tumor-specific dendritic vaccines. |
Innaugural Note as Secretary, SRMTE | ||
Dr. K. G. Rajendran, Consultant, International Stemcell Services Limited, Bengaluru, India Dr. Rajendran has more than 25 years experience in endocrinology research. He has vast expertise in product development and intellectual property rights. He has been instrumental in bringing several DBT programs to fruition. |
|||
![]() |
Dr. Kaushik Deb, Director & CEO, DiponED Biointelligence LLC Dr. Deb is the CEO of DiponEd BioIntelligence LLP a health care biotech company. He started Merisis therapeutics as a division and technology support provider for cell and tissue transplantation needs, to hospitals and clinicians globally, in areas of no-option and unmet medical conditions.
|
Microparticulate gold preparations and gold nanoparticles enhance stemness | |
![]() |
Mr. M. Louis, Muscular Dystrophy Foundation, India
|
||
![]() |
Dr. Mohammed Aejaz Habeeb, Director, Center for Liver Research and Diagnostics, Hyderabad Dr. Habeeb has a DM (Gastroenterology) from AIIMS, Delhi and a Ph. D (Biotechnology) from JNTU, Hyderabad. He has published 40 research papers till now in Scientific Journals of National and International repute.
|
Hepatic stem cells and their applications for liver diseases | |
Dr. Manoj Mojamdar
|
|||
![]() |
Dr. Milind Antani, Nishith Desai Associates
|
Intellectual Property Issues-Managing Licensing Agreement | |
![]() |
Dr. Mrinalini Chaturvedi, Medical Director, Cryobanks International A Post Graduate in Pathology and MBA from Delhi University, Dr. Mrinalini’s special interests lies in Stem Cell Research and Therapeutic applications; Quality Assurance in Cellular Therapy Products. She underwent training in cell manipulation and culture technologies at University of Utah and Da Vinci Biosciences research labs.
|
Cellular Therapy Products: Banking, therapies and future prospects | |
![]() |
Mr. Narayanan Suresh, Group Editor of Biospectrum, Editor, Biospectrum- Asia edition, and MIT’s Technology Review- India edition Narayanan Suresh is the Group Editor of BioSpectrum, India’s first and only Biotechnology business magazine. He has been tracking the growth and strides made by Indian technology sector for 24 years and is sought after as an analyst of India’s technology business trends.
|
Recent Advances in Stem Cells Applications and Indian efforts | |
![]() |
Dr. Oleksandr Kukarchuk, Emprocell Clinical Research Pvt. Ltd., Mumbai Prof. of Medicine, Dr. Olexander L. Kukharchuk, M. D was specialized as “medical practioner” at Chernivtsi Government Medical Institute (Ukraine, Chernivtsi). He has 14 patents, 238 scientific publications to his credit and is the author of the book “Stem cells: Experiment, Theory, Clinic. Embryonic, mesenchymal, neural, hematopoetic stem cells”.
|
Safety issues in using stem cells in medicine | |
![]() |
Dr. Polani Seshagiri, Professor, Dept. of Molecular Reproduction, Development and Genetics, Indian Institute of Science Dr. Polani B. Seshagiri’s academic qualification includes MSc and PhD degrees in Biochemistry and Reproductive Biology with post-doctoral research training in early mammalian development at the University of Wisconsin, Madison, USA.
|
Strategies for derivation and differentiation of pluripotent stem cells from egfp-transgenic mice | |
![]() |
Dr. Pradeep Kiran, M.B.B.S., D'Ortho, DNB Ortho, MCh Sports Medicine (UK), Consultant Orthopedic Surgeon An MBBS from Bangalore University and MCh. Specializing in Sports Medicine from the University of Dundee, Scotland, Dr. Pradeep Kiran is a Consultant Orthopedic Surgeon with Hosmat Hospital, Bangalore. His speciality area are Sports Medicine, Gait analysis, Knee injury management, Arthroplasty and Foot pressure analysis.
|
Role of stem cell implantation in osteoarthritis and cartilage injuries of the knee | |
![]() |
Padma Shree Prof. Ranjit Roy Choudhury, Chairman-Task Force for Research, Apollo Hospitals Educational & Research Foundation Prof. Roychaudhury is a recipient of Dr. B. C. Roy Award, the Shanti Swaroop Bhatnagar Award, the Unichem Award, the Chulalongkorn University Award and the Padma Shree title by the President of India.
|
Stem Cells - Ethical Issues | |
![]() |
Dr. R K Rishi, Pharmacologist, Central Drug Laboratories, Ministry of Health & Family Welfare, Govt. of India
|
Regulatory requirements for clinical trials in India | |
![]() |
Dr. Rao Papineni, Senior Principal Investigator, Research and Development, at Carestream Health Inc, USA Dr. Papineni has a Doctoral degree in Biochemistry from the University of Hong Kong (British Territory) and has initiated advanced research programs to study inflammation and musculo-skeletal biology utilizing molecular imaging and nanotechnology based molecular tools. Dr. Papineni serves on the editorial board of Nanotech and Experimental Pharmacology journals.
|
Molecular Imaging in Cell and Tissue based Therapy | |
![]() |
Dr. Salahudeen, Associate Vice President - Cell Therapeutics, Lifecell International, Chennai. Dr.Salahudeen is a medical scientist hailing from Madurai. He completed his masters in Biochemistry from Madurai Kamarajar University with gold medal where he was working on his thesis on 3 projects related to cancer and cell signaling.
|
Clinical trials using Bone Marrow Derived Stem Cells : The path traversed so far | |
![]() |
Mr. Sanjay Ganapathy, Managing Director, Span Healthcare Pvt. Ltd., Bengaluru Sanjay is a professional with several years of active experience in the field of Transfusion Medicine from both an operational and financial aspect. He has been involved in the field of stem cell derived therapies over the past 15 years.
|
Stem cell therapy: The ideal scenario | |
![]() |
Dr. Sashi Singh, Principal Scientist, Center for Cellular and Molecular Biology, Hyderabad Dr. Shashi Singh got her Ph. D from Dept. of Zoology, University of Delhi specializing Cell Biology / Electron microscopy. Dr. Singh has 57 Papers published, and is a Member of scientific committee for Global Hospitals.
|
Evaluation Of Osteogenic Induction And Biocompatibility Of Biphasic Scaffolds Using Human Mesenchymal Stem Cells | |
![]() |
Dr. Venkatesh Ponemone, Director, Laboratory and Clinical Research Affairs at TotipotentRX Center for Cellular Medicine.
Dr. Ponemone is a post-graduate in Medical Microbiology and Doctoral degree in Oncology and Radiation Biology from Kasturba Medical College, Manipal. He did his post Doctoral training in GI Immunology at the University of Illinois at Chicago, and also holds a certified clinical research professional designation.
|
Marrow Stromal cells in Orthopedics: a Clinical Reality | |
![]() |
Dr. V R Ravi, Chief, Department of Orthopaedic Surgery, Maruti Hospitals, Trichy, Tamilnadu. An experienced Orthopaedic Surgeon in Trichy for the last 20 years. Extensive experience in treating all degrees of fractures for patients of all ages. Currently dealing with Polytrauma as a team at SEAHORSE, KMC & MARUTHI HOSPITALS since 1995.
|
Emerging trends in regenerative orthopedics | |
![]() |
Dr. Vivek Tanavde, Principal Investigator, Bioinformatics Institute, Singapore; Secretary, Stem Cell Society, Singapore Dr. Tanavde obtained his Ph.D from the Cancer Research Institute, Mumbai in Applied Biology. His current research focuses on the use of bioinformatics and systems biology tools to understand mesenchymal stromal cell biology and differentiation.
|
microRNA mediated regulation of differentiation of Mesenchymal Stromal Cells: Connecting miRNA expression to cell signaling |





























